Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-Propofol vs Ketamine-Propofol for CT Guided Bone Biopsy Sedation
NCT05752903Phase 4Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, ketamine in sedation, sponsored by National Cancer Institute. Started Mar 2023; status: completed.
02
Drugs
dexmedetomidineketamine
03
Conditions
sedation
Beyond the preview
Go deeper on NCT05752903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05752903.